Sunday 11 October 2026 Export all MRK data to Excel Powerpack

Merck & Co., Inc.

MRK Healthcare Drug Manufacturers General

Merck & Co., Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.0 billion, up 1.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS fell 130.7%, free cash flow grew 77.0% and total debt rose 50.4%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for twenty-five consecutive years, revenue growth for five.

145.60 3.22 +2.26%

Follow MRK

Alert me

Market cap: $351.3B
P/E: 116×
Fwd P/E: 53.9×
Dividend yield: 2.34%
F-score: 4/9
Altman Z: 3.77
Beneish M: −2.27
Dividend safety: 74/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	11.09	14.46	33.88	102.80
P/S ratio Full definition →		3.26	4.05	4.52	4.77
P/FCF ratio Full definition →		16.05	21.31	21.07	19.76
P/Operating CF Full definition →		26.77	92.18	75.90	59.11
P/B ratio Full definition →		4.03	5.00	6.47	7.56
Price to Tangible BV Full definition →		13.95	59.83	0.00	0.00
EV/Sales Full definition →		3.60	4.55	5.14	5.43
EV/EBITDA Full definition →		8.57	10.58	17.60	26.38
EV/Operating CF Full definition →		13.55	17.94	18.91	18.10
EV/FCF Full definition →		17.71	23.91	23.97	22.49
Quick Ratio Full definition →		1.06	0.93	0.66	0.71
Current Ratio Full definition →		1.66	1.54	1.30	1.32
Net Debt/EBITDA Full definition →		2.82	4.93	(24.26)	38.21
Debt/Assets Full definition →		30.85%	34.16%	36.27%	39.35%
Debt/Equity Full definition →		0.77	0.89	1.02	1.22
Asset Turnover Full definition →		0.52	0.51	0.54	0.54
Operating CF/Net income Full definition →		1.35	0.96	(0.92)	(4.02)
Capex/Depreciation Full definition →		(0.86)	(0.42)	(0.66)	(0.56)
Research and Development Expense of Revenue Full definition →		24.51%	23.70%	77.32%	58.66%
Selling, General and Administrative Expense of Revenue Full definition →		15.24%	17.68%	16.58%	17.49%
Intangible Assets out of Total Assets Full definition →		0.28	0.35	0.37	0.36
Share Based Compensation of Revenue Full definition →		1.18%	1.25%	1.14%	1.79%
Graham Net Nets Full definition →		(0.14)	(0.15)	(0.16)	(0.16)
Graham Number Full definition →		59.53	58.72	38.52	21.86
Earnings Yield Full definition →		9.02%	6.92%	2.95%	0.97%
Free Cash Flow Yield Full definition →		6.23%	4.69%	4.75%	5.06%
Revenue per Share Full definition →		6.92	6.55	6.59	6.72
Operating CF per Share Full definition →		3.14	1.14	1.59	2.17
Capex per Share Full definition →		(0.40)	(0.41)	(0.40)	(0.36)
Free Cash Flow per Share Full definition →		2.74	0.73	1.18	1.81
Cash per Share Full definition →		7.30	5.82	2.31	2.89
Shareholders Equity per Share Full definition →		20.80	21.05	18.58	17.00
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		20.80	21.05	18.58	17.00
Free Cash Flow Full definition →		6,835.00	1,824.00	2,927.00	4,477.00
Working Capital Full definition →		18,929.00	15,189.00	8,070.00	8,948.00
Capital Expenditures Full definition →		(987.00)	(1,033.00)	(991.00)	(893.00)
Net Current Asset Value Full definition →		(30,082.00)	(40,688.00)	(47,739.00)	(51,139.00)
EV/EBIT Full definition →		10.32	13.37	26.09	51.74
Capex to Sales Full definition →		0.06	0.06	0.06	0.05
Price to Operating Income Full definition →		9.35	11.91	22.93	45.45
Other line items
Average Receivables Full definition →		11,750.50	11,026.50	11,500.00	12,205.00
Average Payables Full definition →		3,866.50	4,241.50	3,823.50	3,859.50
Average Inventory Full definition →		6,344.00	6,383.50	6,337.50	6,404.00
Average Assets Full definition →		123,539.00	126,986.00	121,903.50	123,662.50
Average Common Equity Full definition →		48,233.50	49,517.00	47,165.50	45,522.00

Fold the line items

Columns are period end dates

Stockrow Weekly